For example, recent reports described that inhibition of BCL2 and autophagy can enhance crizotinib-induced inhibition on ALK + ALCL cell viability, suggesting that BCL2 and the autophagy pathway contribute to crizotinib resistance in these cells [27]. This evidence concerns the gene BCL2 and anaplastic large cell lymphoma.